Download presentation
Presentation is loading. Please wait.
Published byBeverly Bryan Modified over 5 years ago
1
Maribavir for Treatment of Cytomegalovirus Infections Resistant or Refractory to Ganciclovir or Foscarnet in Hematopoietic Stem Cell Transplant or Solid Organ Transplant Recipients: A Randomized, Dose-Ranging, Double-Blind, Phase 2 Study Genovefa A. Papanicolaou, Fernanda P. Silveira, Amelia A. Langston, Marcus R. Pereira, Robin K. Avery, Anna Wijatyk, Jingyang J. Wu, Michael J. Boeckh, Francisco M. Marty, Stephen Villano Biology of Blood and Marrow Transplantation Volume 23, Issue 3, Pages S56-S57 (March 2017) DOI: /j.bbmt Copyright © Terms and Conditions
2
Biology of Blood and Marrow Transplantation 2017 23, S56-S57DOI: (10
Biology of Blood and Marrow Transplantation , S56-S57DOI: ( /j.bbmt ) Copyright © Terms and Conditions
3
Biology of Blood and Marrow Transplantation 2017 23, S56-S57DOI: (10
Biology of Blood and Marrow Transplantation , S56-S57DOI: ( /j.bbmt ) Copyright © Terms and Conditions
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.